Dicerna Pharmaceuticals (DRNA) PT Raised to $15 at SunTrust Robinson Humphrey
Tweet Send to a Friend
SunTrust Robinson Humphrey raised its price target on Dicerna Pharmaceuticals (NASDAQ: DRNA) to $15.00 (from $13.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
